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Primary cilia are sensory organelles involved in regulation of cellular signalling. Cilia loss is 32 
frequently observed in tumors, yet the responsible mechanisms and consequences for 33 
tumorigenesis remain unclear. We demonstrate that cilia structure and function is disrupted in 34 
human pheochromocytomas - endocrine tumours of the adrenal medulla. This is concomitant with 35 
transcriptional changes within cilia mediated signalling pathways that are associated with 36 
tumorigenesis generally and pheochromocytomas specifically. Importantly, cilia loss was most 37 
dramatic in patients with germline mutations in the pseudohypoxia-linked genes SDHx and VHL. 38 
Using a pheochromocytoma cell line derived from rat, we show that hypoxia and oncometabolite 39 
induced pseudohypoxia are key drivers of cilia loss and identify that this is dependent on activation 40 
of an AuroraA/HDAC6 cilia resorption pathway. We also show cilia loss drives dramatic 41 
transcriptional changes associated with proliferation and tumorigenesis. Our data provide evidence 42 
for primary cilia dysfunction contributing to pathogenesis of pheochromocytoma by a 43 
hypoxic/pseudohypoxic mechanism and implicates oncometabolites as ciliary regulators. This is 44 
important as pheochromocytomas can cause mortality by mechanisms including catecholamine 45 
production and malignant transformation, while hypoxia is a general feature of solid tumours. 46 
Moreover, pseudohypoxia induced cilia resorption can be pharmacologically inhibited, suggesting 47 
potential for therapeutic intervention. 48 
 49 




Pheochromocytomas (PCC) are neuroendocrine tumors that originate from chromaffin cells of the 53 
adrenal medulla or autonomic nervous system, where they are termed paragangliomas (PGL). The 54 
majority of the morbidity associated with PCC/PGLs is consequent upon their production of 55 
catecholamines, leading to severe, life-threatening hypertension, but they may also cause local 56 
mass effect and have the potential for metastatic spread (Burnichon, et al. 2016; Fishbein and 57 
Nathanson 2012). Understanding of the pathogenesis of PCC/PGLs is incomplete, with limited 58 
ability to predict malignant potential and at present the response to conventional cancer therapies 59 
is disappointing. 60 
 61 
Approximately 30% of PCC/PGL are associated with inherited germline mutations in more than 15 62 
different susceptibility genes (Dahia 2017). These include causative genes for inherited cancer 63 
syndromes, where, relative to other tumor types, there is a high incidence of PCC/PGL. Recent 64 
analyses of germline and somatic mutations have classified PCC/PGL into four molecularly defined 65 
groups, including a pseudohypoxia-linked subtype (Fishbein, et al. 2017). These pseudohypoxic 66 
tumors occur due to mutations that impact regulation of the hypoxia transcription factors HIF1a 67 
and HIF2a. This can be through germline or somatic mutation of the ubiquitin E3 ligase pVHL (von 68 
Hippel Lindau protein), which targets HIFa for degradation by the ubiquitin proteasome system 69 
(Crespigio, et al. 2017; Dannenberg, et al. 2003; Gossage, et al. 2015). Increased HIF activity also 70 
results from germline mutation in genes that encode the succinate dehydrogenase (SDH) complex 71 
subunits (SDHA, SDHB, SDHC, SDHD), succinate dehydrogenase complex assembly factor 2 72 
(SDHAF2), fumarate hydratase (FH) and malate dehydrogenase (MDH2) (Fishbein and Nathanson 73 
2012). This is because loss of their function leads to accumulation of oncometabolites that inhibit 74 
pVHL-mediated degradation of HIFa (Selak, et al. 2005). 75 
 76 
Although pseudohypoxic mechanisms account, at least in part, for angiogenesis-facilitated growth, 77 
they do not, of themselves, satisfactorily explain PCC/PGL tumorigenesis. Mutations in the VHL 78 
gene are known to be important in renal cancers; this includes the occurrence of clear cell renal 79 
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cell carcinoma (ccRCC) as part of the inherited cancer syndrome von Hippel-Lindau disease, in 80 
which VHL is mutated and PCC/PGL can occur (Crespigio et al. 2017; Gossage et al. 2015). One 81 
of the hallmark features of ccRCC is the loss of primary cilia (Basten, et al. 2013), which act as 82 
flow sensors on renal epithelial cells. Cilia are cellular organelles that consist of a microtubule-83 
based core structure, known as the axoneme, that elongates from a basal body and is covered by 84 
the ciliary membrane. Cilia function as signalling platforms involved in the transduction of 85 
extracellular stimuli, through mechanisms including regulating the spatial compartmentalisation of 86 
signalling components (Berbari, et al. 2009; Goetz and Anderson 2010). For example, primary cilia 87 
are modulators of Wnt signalling and have an essential role in mammalian hedgehog (Hh) 88 
signalling (Berbari et al. 2009; Goetz and Anderson 2010; Lancaster, et al. 2011; Oh and Katsanis 89 
2013; Wong, et al. 2009). 90 
 91 
The coordination of cilia-mediated signalling is influenced by the dynamic nature of cilia, which 92 
elongate and shorten in response to cell cycle stage and other stimuli. This requires the process of 93 
intraflagellar transport (IFT) to traffic ciliary components in both anterograde and retrograde 94 
directions along axonemal microtubules. Cilia are assembled when cells enter stationary phase 95 
and are normally resorbed prior to cell division. This occurs as the basal body, which acts as a 96 
nucleation site for the growth of axoneme microtubules during ciliogenesis, is derived from a 97 
mother centriole and is required for mitotic spindle pole formation. Importantly, the mother centriole 98 
has this dual role means that the presence of a primary cilium potentially acts as a checkpoint 99 
within the cell cycle (Izawa, et al. 2015). Thus, cilia might oppose cell division and proliferation, 100 
however it should be noted that there are instances where cilia are present on mitotic cells (Goto, 101 
et al. 2013). Dysregulation of normal restraints on cellular proliferation is required for neoplastic 102 
progression and it is hypothesized that disruption of a ciliary cell cycle checkpoint may promote 103 
tumorigenesis (Mans, et al. 2008), although ciliopathy patients have not been identified as having 104 
an increased risk of cancer (Johnson and Collis 2016). 105 
 106 
Here we address key questions regarding the loss of cilia in tumor cells in the context of 107 
PCC/PGLs. These include whether cilia loss is correlated with changes in cilia mediated signalling 108 
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in vivo. We also consider whether cilia loss increases cellular proliferation or is a consequence of 109 
it. We demonstrate that primary cilia loss is a feature of PCC/PGL and in particular those that are 110 
driven by germline mutations in pseudohypoxia linked genes. This finding is consistent with 111 
transcriptome based evidence from PCCs for dysregulation of cilia maintenance and cilia-mediated 112 
signalling pathways. Using a rat PCC derived cell line (PC12) we define the molecular mechanism 113 
of primary cilia loss, demonstrating that axonemal resorption is dependent on both HIF signalling 114 
and Aurora-A kinase activation. Moreover, loss of primary cilia in PC12, induced by ciliary protein 115 
knockdown, leads to increased proliferation and alterations in expression of genes associated with 116 
pathways involved in proliferation and cancer. We also show that knockdown of pseudohypoxia 117 
causing PCC/PGL genes and treatment with inhibitors that trigger accumulation of 118 
oncometabolites results in primary cilia loss. 119 
  120 
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Materials and Methods 121 
 122 
Tissue sample collection and preparation for immunolabelling and RNA extraction 123 
Samples of tumor and adjacent adrenal medulla, where available, were collected at the time of 124 
adrenalectomy (for PCC) or PGL resection (patient recruitment and ethical approval is described in 125 
the supplemental information). PCC and normal adrenal medulla were differentiated at the time of 126 
surgery with subsequent pathology analysis. For immunofluorescence, samples were fixed in 4% 127 
paraformaldehyde, resuspended in 30% sucrose and embedded in OCT compound (VWR) prior to 128 
storage at -80oC. For RNA extraction, tissue samples were placed directly into RNAlater™ 129 
(Thermo Fisher Scientific) and stored at -20oC. Samples were subsequently homogenized in RLT 130 
buffer and purified using RNeasy Mini Kit (Qiagen). 131 
 132 
Cell culture and experimental treatments  133 
Cell lines were cultured and treated with drugs as described in supplemental information. PC-12 134 
Adh (ATCC® CRL-1721.1™) cells were obtained from the American Type Culture Collection; for 135 
cilia assembly experiments, cells were plated and grown in complete media for 24 hours prior to 136 
serum starvation for a further 24 hours or otherwise specified. For cilia disassembly experiments 137 
serum-containing media was reintroduced for 24 hours after starvation or as otherwise specified.  138 
 139 
Immunofluorescent detection and quantification of primary cilia 140 
The immmunostaining protocols and antibodies used are described in supplemental information. 141 
Confocal microscopy was performed using an LSM510 or LSM880 laser scanning confocal 142 
microscope (Zeiss). Quantification of cilia incidence and length was performed blinded to 143 
experimental status. Cilia incidence was defined as the number of cells with a cilium (identified by 144 
two axonemal markers) divided by the number of nuclei in a given field. Cilia length was measured 145 
from maximum intensity projections created from confocal Z-stacks using Zen (Zeiss) and ImageJ 146 
(NIH) software. The surpass module of Imaris 7.1 image processing and analysis software 147 
(Bitplane) was used to surface render 3D images. 148 
 149 
 7 
siRNA mediated knockdown 150 
PC12 cells were transfected with either targeted or non-targeted control siRNAs (Silencer Select, 151 
Ambion) using Lipofectamine 3000 (Thermo Fisher Scientific), according to the manufacturer’s 152 
instructions. For knockdown of VHL, SDHB and FH, IFT88 and Cep164 two distinct siRNAs each 153 
targeting distinct exons were used at a total concentration of 30nM (sequences available on 154 
request). 155 
 156 
RNA-sequence data and pathway analyses 157 
RNA extraction and sequencing is described in supplemental information. All analysis was 158 
conducted in the R statistical environment, version 3.4.0, using software from the Bioconductor 159 
repository (Huber, et al. 2015). Functional analysis of differential gene expression between control 160 
and IFT88 knockdown cells was performed using Ingenuity Pathways Analysis (IPA; Ingenuity 161 
Systems), using all genes with log fold change ≥ 2 and q-value was <0.01, as input. For all gene 162 
set enrichment analyses, a right-tailed Fisher’s exact test was used to calculate a pathway p-value 163 
determining the probability that each biological function assigned to that data set was due to 164 
chance alone. All enrichment scores were calculated in IPA using all transcripts that passed QC as 165 
the background data set. For more details of transcriptome and pathway analyses, see our 166 
supplemental R Markdown document (https://github.com/C4TB/markdown-chapple_pcc).  167 
 168 




The incidence and length of primary cilia is reduced in PCCs relative to adjacent normal 172 
adrenal medulla. 173 
We collected paired tissue samples from PCCs and adjacent macroscopically normal adrenal 174 
medulla from 25 patients who underwent adrenalectomy. Two individuals had bilateral disease 175 
giving a total of 27 paired samples (Table 1 and Table S1). The tissues were immunostained for 176 
the axonemal proteins acetylated α-tubulin and ADP-ribosylation factor-like protein 13B (Arl13b) 177 
and analysed for the incidence of cells with a primary cilium (Figure 1A). This showed that the 178 
occurrence of a primary cilium was lower (p=4.74x10-11) in PCCs (3.06±0.14% of cells) compared 179 
to adrenal medulla (8.42±0.03% of cells) (Figure 1B). The length of the ciliary axoneme was also 180 
reduced (p=8.24x10-11) in PCC cells that still had cilia (1.48+0.34μm) relative to cells in adjacent 181 
adrenal medulla (2.02±0.39μm) (Figure 1C). The incidence and length of primary cilia measured in 182 
individuals correlated in both PCCs and adjacent adrenal medulla, although this relationship was 183 
stronger in PCCs than adjacent adrenal medulla (PCC p<0.001, r2=0.66; adrenal p=0.001, r2=0.36) 184 
(Figure 1D). We also observed that in every instance cilia incidence was lower in the PCC than its 185 
adjacent adrenal medulla (Figure S1A). This was also the case for cilia length in all but one of the 186 
paired samples (Figure S1B). Together, these data established that loss of primary cilia is a 187 
feature of PCC. 188 
 189 
It has previously been reported that the tumor suppressor pVHL plays a role in ciliogenesis 190 
(Schermer, et al. 2006). Thus, we next compared cilia loss and length reduction in PCC from 191 
patients with germline mutations in VHL compared to those without. We found that both cilia 192 
incidence (1.40±0.01% v. 3.43±0.02) and length (1.15±0.35μm v. 1.58±0.31μm) were reduced in 193 
VHL-PCCs compared to non-VHL-PCCs (p=0.010 for incidence, p=0.010 for length (Figure 1E, F). 194 
There was no significant difference in either cilia incidence or length in adjacent adrenal medulla 195 
from VHL and non-VHL patients (Figure 1E, F). This suggests that cilia loss and shortening in 196 
VHL-PCCs occurs during tumorigenesis and is not a pre-existing/pre-malignant feature. 197 
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 198 
In order to further evaluate whether this finding was specific to VHL or a feature of other 199 
pseudohypoxic PCCs, we extended our analysis to include an additional 20 tumors from 15 200 
patients from whom a paired adrenal sample was unavailable (total 47 PCC/PGL from 40 patients; 201 
Table 1 and Table S2). We compared PCC/PGLs from patients with germline mutations in VHL, to 202 
tumors from patients with germline mutations in SDHx and those without a known germline 203 
mutation in a pseudohypoxia linked gene. Cilia incidence was reduced in PCC/PGLs from patients 204 
with germline mutations in VHL (p=0.0007) and SDHx (p=0.0103 for incidence), relative to 205 
PCC/PGLs from patients that were not of a pseudohypoxia-linked subtype (Figure 1G). Cilia length 206 
was also reduced in VHL- and SDHx-PCC/PGLs relative to the non-pseudohypoxia tumors, 207 
although this was only significant for VHL (p=0.0013) (Figure 1H).  208 
 209 
We also examined if there was any correlation between cilia loss and clinical disease parameters 210 
in patients with PCC/PGL. Patients under 18 years of age at the time of surgery had tumor cells 211 
with fewer and shorter cilia than patients who were over the age of 18 (Figure S1C, D), suggesting 212 
association between cilia loss and age (at time of surgery). As the presence of a primary cilium is 213 
potentially a checkpoint for cell division we next tested if cilia loss correlated with cellular 214 
proliferation in PCC/PGLs. This was by quantifying the percentage of cells that labelled positively 215 
for Ki67 (quantified by routine clinical immunohistochemistry), a marker of proliferative activity that 216 
has previously been correlated with malignant potential in PCCs (Clarke, et al. 1998; Kimura, et al. 217 
2014). Cilia incidence was reduced in PCCs/PGLs that had a Ki67 index of 3% or higher 218 
(p=0.0159) compared to PCC/PGLs with a lower Ki67 index (p=0.0159). (Figure 1I). These data 219 
indicate that degree of cilia loss is linked to clinical parameters in PCC/PGLs. 220 
 221 
Dysregulation of cilia-mediated signalling pathways in PCCs 222 
We hypothesized that the reduced incidence and length of primary cilia in PCCs, relative to 223 
adrenal medulla, may result in alterations in cilia-mediated signalling. This was examined using 224 
RNA-Seq transcriptome analysis of 12 PCCs and adjacent adrenal medulla (Table S1) to identify 225 
differentially expressed cilia-linked gene networks. We performed principal component analysis 226 
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(PCA) on the filtered, normalised, and transformed count matrix to explore the data’s latent 227 
structure (Figure 2A). This revealed that principal component 1, which accounts for nearly 40% of 228 
all variation in the counts, separated the PCC samples from adjacent adrenal medulla. PCC 229 
samples were spread along principal component 2, which accounts for over 10% of data variance, 230 
indicating a heterogeneity in this group that is absent in adjacent adrenal medulla, where samples 231 
cluster together more closely. 232 
 233 
Our unsupervised analysis suggested a strong transcriptomic signal differentiating tumor and 234 
adrenal medulla samples. To quantify this and identify relevant biomarkers, we conducted 235 
differential expression analysis using the DESeq2 software package (Love, et al. 2014). We 236 
defined a gene as differentially expressed if its absolute log fold change ≥ 2 and its q-value was £ 237 
0.01, imposing a false discovery rate of 1%. This strict threshold ensured high specificity. 1,839 238 
genes met these criteria, representing some 8% of the transcriptome after filtering (Figure 2B).  239 
 240 
To test if cilia function was altered in PCC relative to adjacent adrenal medulla, we curated a 241 
collection of 32 gene sets known to be associated with cilia structure and cilia-mediated signalling. 242 
We found considerable enrichment among these pathways (14 out of 32 at q £ 0.1). Eigengenes 243 
for all modules are depicted in Figure 2C. Altered gene modules included those associated with 244 
cilia structure. For example, the GO_NONMOTILE_PRIMARY_CILIUM module showed altered 245 
expression in PCC tissue relative to adrenal medulla (q=0.0519) (Figure 2D), suggesting changes 246 
in gene expression may contribute to cilia loss in PCCs. We also observed changes in the Aurora-247 
A gene module (q=0.2365), which is of interest as activation of Aurora-A pathway plays a role in 248 
regulation of cilia disassemble. 249 
 250 
We also identified that gene modules associated with Hedgehog, Wnt and NOTCH signalling were 251 
altered between PCCs and adrenal medulla e.g. HALLMARK_HEDGEHOG_SIGNALING 252 
(q=1.66x10-7), BIOCARTA_WNT_PATHWAY (q=0.0519) and 253 
GO_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY (q=1.58x10-6). Analyses of 254 
these gene modules revealed significant up and down regulation of individual genes (absolute log 255 
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fold change ≥ 2, q £ 0.01), while hierarchical clustering analyses separately grouped tumor and 256 
adrenal medulla samples in each of these pathways, with the exception of one medulla sample 257 
(H21) in the Hedgehog and Notch pathways, and two tumor samples (H10 and H22) in the Wnt 258 
pathway (Figure 2D-G). These data are consistent with cilia-mediated signalling pathways being 259 
disrupted in PCC, but could also be explained by other potential mechanisms. 260 
 261 
Disruption of primary cilia function in the PCC-derived PC12 cell line promotes proliferation 262 
and alters expression of tumorigenesis linked gene networks 263 
It is not fully resolved whether cilia loss is a driver or consequence of tumorigenesis. To address 264 
this question, in the context of PCC, we first established that PCC derived cultured cell lines are 265 
able to form primary cilia. This was confirmed in the rat tumor derived PC12 cell line, with cilia 266 
incidence and length increasing after serum starvation, such that 55.4±5.98% of cells had a 267 
detectable cilium with a mean axonemal length of 2.17±0.69μm after 24 hours (Figure 3A-C; 268 
Figure S2A-C). Cilia were also present and responsive to serum-starvation in two mouse PCC cell 269 
lines, MPC and MTT (Figure S2D-F). It should be noted that PC12 cells do not express the Myc 270 
dimerization partner MAX, while MPC and MTT lines were derived from the neurofibromatosis type 271 
1 (NF1) knockout mouse (Burnichon, et al. 2012; Hopewell and Ziff 1995; Korpershoek, et al. 272 
2012). 273 
 274 
We next disrupted cilia function in PC12 cells through siRNA-mediated knockdown of either the 275 
IFT88, a central component of the intraflagellar transport complex (Pazour, et al. 2000), or 276 
Cep164, which plays a role in microtubule organization and/or maintenance for the formation of 277 
cilia (Graser, et al. 2007). IFT88 knockdown was confirmed by immunoblot (Figure S3A, B), while 278 
knockdown of Cep164 was confirmed at the level of transcript (Figure S3C). Knockdown cells were 279 
then immunolabelled to detect cilia and stained with the proliferation marker Ki67 (Figure 3D). 280 
Quantitative analysis confirmed, compared to control cells transfected with a non-targeting siRNA, 281 
that cilia incidence was reduced in both IFT88 (p=0.02577) and Cep 164 knockdown cells (p=0. 282 
0.00222) (Figure 3E, H). Cilia length was also reduced in both instances (Figure S3D, E). 283 
Moreover, the percentage of Ki67 positive cells was increased after both IFT88 knockdown 284 
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(p=4.35x10-12) and Cep164 knockdown (p=0.03937) (Figure 3F, I). Increased proliferation of IFT88 285 
and Cep164 knockdown PC12 cell, relative to controls, was further confirmed by quantification of 286 
cell numbers 48 hours after siRNA transfection (Figure 3G, J). 287 
 288 
To further understand how disruption of cilia function impacts on cellular proliferation we compared 289 
the transcriptomes of IFT88 knockdown and control cells (transfected with non-targeting siRNA) by 290 
RNA-Seq. Reads were pseudo-aligned (using the same pipeline as described for PCC and adrenal 291 
medulla) and PCA performed. PC1 separated IFT88 knockdown and control cells, accounting for 292 
over 30% of the variation in the counts (Figure S3F). We found 662 genes differentially expressed 293 
at q£0.01 (Figure S3G), representing some 6% of the transcriptome after filtering. Ingenuity 294 
Pathways Analysis was then used to identify statistically significant functions of the differentially 295 
regulated genes. This Gene Ontology (GO) analysis revealed that the top 10 biological processes 296 
of these genes were related to cell death, cell proliferation and tumorigenesis. Moreover, activation 297 
z-scores suggested that cell death pathways were inhibited while proliferation and tumorigenesis 298 
pathways were induced (Figure 3K). Hierarchical cluster analysis of gene modules described by 299 
the GO terms ‘cell death’, ‘tumorigenesis of tissues’, and ‘cell proliferation of tumor cells’ clearly 300 
separated IFT88 knockdown samples from controls (Figure 3L-N). These data suggest that cilia 301 
loss promotes proliferation of PC12 cells. 302 
 303 
PC12 cells resorb primary cilia under hypoxic conditions 304 
Primary cilia incidence was most reduced in tumors with germline mutations in VHL and SDHx 305 
(Figure 1G). This suggested that hypoxic signalling may be a driver of cilia loss. To test this 306 
hypothesis, we exposed ciliated PC12 cells (grown in serum free conditions for 24 hours) to normal 307 
cell culture oxygen levels (21% O2) and hypoxic conditions (1% O2). Cells were then 308 
immunolabelled to detect cilia. Subsequent confocal imaging and quantitative analysis 309 
demonstrated that culture of ciliated PC12 cells in 1% O2 caused a reduction in cilia incidence 310 
(p=3.75x10-15) and length (p=0.0106) (Figure 4A-C). This cilia resorption was shown to be 311 
transient, with PC12 cells able to reform primary cilia within 24 hours of return to 21% O2 (Figure 312 
4B, C). We also looked at the effect of oxygen levels on ciliogenesis. Cilia formation, induced by 313 
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culture in serum free conditions, was compared in cells maintained under normoxic (21% O2) and 314 
hypoxic conditions (1% O2). Lowered oxygen levels again resulted in cells having a reduction in 315 
cilia incidence (p=1.27x10-5) and length (p=0.0075) (Figure 4D, E). To further confirm cilia loss 316 
occurred in PCC derived cell lines cultured under hypoxic conditions we immunolabelled MPC and 317 
MTT cells to detect cilia. In MPC and MTT cell lines primary cilia incidence (MPC p=0.002; MTT 318 
p=0.0351) and length (MPC p=1.00x10-15; MTT p=0.0001) was reduced after transfer to 1% O2 for 319 
24 hours (Figure S4). 320 
 321 
To investigate if the loss of primary cilia under hypoxic conditions was dependent on HIF-mediated 322 
signalling we added the HIFa inhibitor FM19G11 (Moreno-Manzano, et al. 2010) to culture media 323 
prior to transfer of cells to 1% O2. Compared to vehicle only treated control cells, FM19G11 324 
prevented hypoxia induced cilia loss (p=8.68x10-5 for incidence, p=7.08x10-6 for length) (Figure 4F, 325 
G; Figure S4D). We further tested a role for HIF1a signalling in hypoxia induced cilia loss by 326 
targeting with siRNA. This showed that HIF1a knockdown was able to rescue cilia loss in PC12 327 
cells cultured in 1% O2 (Figure 4H, I; Figure S4E, F).  To further understand the mechanism of 328 
hypoxia induced cilia loss we next tested for involvement of the Aurora-A kinase/histone 329 
deacetylase 6 (HDAC6) pathway. Activation of Aurora-A has been shown to cause phosphorylation 330 
of HDAC6, which deacetylates ciliary tubulin and destabilises the axonemal microtubules 331 
(Pugacheva, et al. 2007). Inhibition of Aurora-A, with the specific inhibitor PHA-680632, prevented 332 
cilia loss (p=1.85x10-7) and shortening (p=2.94x10-6) in cells exposed to 1% O2 (Figure 4J, K; 333 
Figure S4D). Hypoxia induced cilia loss was also inhibited by the mammalian class I and II HDAC 334 
inhibitor trichostatin A (TSA) (p=3.22x10-8 for incidence, p=3.29x10-8 for length) and the selective 335 
HDAC6 inhibitor tubacin (p=1.11x10-4 for incidence, p=0.0487 for length) (Figure 4J, K; Figure 336 
S4D). These data suggest that reduced oxygen levels lead to cilia resorption in PC12 cells by a 337 
mechanism that includes HIF signalling and activation of the Aurora-A kinase/HDAC6 pathway. 338 
 339 
In addition to degradation of HIF, pVHL stabilizes microtubules and plays a role in cilia 340 
maintenance. It is reported that loss of pVHL alone does not affect cilia structure but may sensitise 341 
cells to lose pre-established cilia (Thoma, et al. 2007). pVHL has been shown to localize to the 342 
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ciliary axoneme, and this was also the case in PC12 cells (Figure S4G). We thus investigated if 343 
activation of hypoxic signalling effected localisation of pVHL by quantifying levels of the protein in 344 
the axoneme. Ciliary axonemes were detected by immunolabelling for acetylated tubulin and levels 345 
of pVHL that localised within the region of the cilia determined by analyses of fluorescent intensity. 346 
This showed that pVHL levels were reduced (p=0.0234) in the cilium of cells maintained at 1% O2 347 
relative to cells maintained at 21% O2 (Figure S4H). Thus, activation of hypoxic signalling may also 348 
destabilize cilia through a mechanism where pVHL is reduced in the ciliary axoneme. 349 
 350 
 351 
Pseudohypoxia in PC12 cells results in primary cilia loss and shortening 352 
Under normoxic conditions HIFa is hydroxylated at conserved proline residues by HIF prolyl-353 
hydroxylases (HIF-PHDs). This leads to recognition of HIFa by VHL, facilitating their ubiquitination 354 
and subsequent proteasomal degradation. Thus, direct inactivation of either HIF-PHDs or VHL can 355 
result in persistence of HIFα and transcription of HIF target genes even in the presence of oxygen - 356 
pseudohypoxia. Moreover, succinate, which accumulates as a result of loss of SDH function, 357 
inhibits HIF-PHDs, again resulting in pseudohypoxia (Figure 5A). To establish if pseudohypoxia 358 
impacted primary cilia we firstly targeted HIF-PHs by treating PC12 cells with the inhibitor 359 
dimethyloxalylglycine, N-(methoxyoxoacetyl)-glycine methyl ester (DMOG). This resulted in 360 
reduced cilia incidence (p=3.86x10-11) and length (p=8.00x10-14) (Figure 5B, C; Figure S5A). We 361 
next tested if drivers of the pseudohypoxic PCC/PGL phenotype resulted in cilia loss. For SDHB, 362 
siRNA mediated knockdown (Figure S5B-D) again lead to a reduction in cilia incidence 363 
(p=1.20x10-8) and length (p=0.00124) (Figure 5D, E). Cilia loss also occurred in the presence of 364 
malonate, which competes with succinate for active sites of SDH (Figure 5F, G; Figure S5E). 365 
Malonate inhibition of SDH can be reversed by pharmacologically elevating intracellular α-366 
ketoglutarate (MacKenzie, et al. 2007). Consistent with this we observed that addition of α-367 
ketoglutarate to PC12 cells rescued the cilia loss phenotype observed in cells treated with 368 
malonate alone (Figure 5H, I; Figure S5E). Similar to succinate, accumulation of fumarate, another 369 
citric acid cycle intermediate, inhibits HIF-PHDs (this is also linked to disease as germline 370 
mutations in FH cause PCC/PGL). We inhibited FH using the cell-permeable derivative of 371 
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fumarate, monomethyl fumarate. This again resulted in reduction in cilia incidence (p=1.67x10-5) 372 
and length (p=2.28x10-17) (Figure 5J, K; Figure S5F). The same pattern of reduced cilia incidence 373 
(p=4.11x10-6) and length (p=5.75x10-19) was observed when siRNA mediated knockdown of FH 374 
(Figure S5G-I) was performed (Figure 5L, M).  375 
 376 
Finally, we investigated the effect of siRNA-mediated knockdown of VHL (Figure S5J-L) on primary 377 
cilia. Quantification of cilia incidence and length showed that VHL knockdown resulted in fewer 378 
cells exhibiting a cilium (p=6.93x10-13) and that mean cilia length was decreased (p=8.12x10-14) 379 
(Figure 5N, O). In summary, these data show cilia loss was induced by a number of different 380 
conditions that impair HIFa degradation, including those that lead to accumulation of 381 
oncometabolites. Importantly, knockdown of SDHB and VHL also resulted in increased Ki67 382 
labelling and cell number, relative to control cells transfected with a non-targeting siRNA (Figure 383 
5P, Q). This is consistent with pseudohypoxia-induced cilia loss correlating with increased cellular 384 
proliferation. 385 
 386 
Inhibition of both the Aurora-A/HDAC6 cilia resorption pathways and of hypoxic signalling 387 
prevents cilia loss in SDHB and VHL knockdown cells. 388 
To understand why cilia incidence and length was reduced upon depletion of SDHB or VHL we 389 
tested whether inhibition of the Aurora-A/HDAC6 pathway prevented cilia loss. PC12 cells were 390 
transfected with siRNAs targeting SDHB or VHL and then cultured in media containing PHA-391 
680632, TSA, tubacin or vehicle only as a control. 48 hours after transfection cells where fixed and 392 
cilia immunolabelled for confocal microscopy. Quantification of cilia incidence and length showed 393 
that treatment with the Aurora-A inhibitor PHA-680632 and the HDAC inhibitors TSA and tubacin 394 
reduced cilia loss and shortening in response to pVHL and SDHB (Figure 6A-D; Figure S6) 395 
knockdown. Inhibition of HIF signalling with FM19G11 also reduced cilia loss in both SDHB and 396 
VHL depleted cells (Figure 6A-D; Figure S6). Together these data indicate that the Aurora-397 
A/HDAC6 pathway is a modulator of cilia loss in PC12 cells depleted for SDHB or pVHL. 398 
 399 




Data presented here are the first to show that primary cilia are lost from PCCs compared to normal 403 
adjacent adrenal medulla. This corresponds with observations that primary cilia structure and 404 
function is disrupted in a broad range of cancers (O'Toole and Chapple 2016). These include 405 
breast, prostate, renal, pancreatic, melanoma, cholangiocarcinoma, glioblastoma, 406 
chondrosarcoma, and colon cancer (Gradilone, et al. 2013; Hassounah, et al. 2013; Ho, et al. 407 
2013; Kim, et al. 2011; Moser, et al. 2009; Rocha, et al. 2014; Schraml, et al. 2009; Seeley, et al. 408 
2009; Yuan, et al. 2010). In PCCs the degree of cilia loss was more pronounced in tumors from 409 
patients with germline mutations in pseudohypoxia linked genes VHL and SDHB. For pVHL this 410 
may be partly explained by its reported non-canonical function in ciliogenesis, through orienting 411 
growth of microtubules toward the cell periphery (Schermer et al. 2006). Cilia frequency is also 412 
reduced relative to neighbouring tissue in ccRCC. The VHL gene is inactivated in the majority 413 
(87%) of sporadic clear cell RCCs (Moore, et al. 2011), with ccRCCs also occurring as part of von-414 
Hippel Lindau disease (Crespigio et al. 2017; Gossage et al. 2015). Contrasting ccRCC, VHL 415 
inactivation is a much less common feature of sporadic PCCs (Burnichon, et al. 2011; Dannenberg 416 
et al. 2003). In the context of our data, this suggests that although disruption of a cilia specific 417 
function of VHL may contribute to loss of cilia in PCC, it is not the main mechanism responsible for 418 
cilia loss.  419 
 420 
Using the PCC derived PC12 cell line we found that siRNA-mediated depletion of SDHB, FH and 421 
VHL all resulted in reduction of cilia frequency. We also observed that treatment of cells with drugs 422 
that inhibit HIF-PHs, SDH and FH, leading to accumulation of oncometabolites for SDH and FH, 423 
caused cilia loss. Culture of PC12 cells in conditions of reduced oxygen similarly reduced the 424 
incidence of cilia, although it should be noted the change in oxygen concentration from 21% 425 
(standard for cell culture) to 1% is greater than will to occur in vivo, where physiological levels of 426 
oxygen range from 2-9% (Tiede, et al. 2011). Together these data implicate 427 
pseudohypoxic/hypoxic signalling as a regulator of cilia dynamics. This is further supported by the 428 
finding that inhibition of HIF signalling reduced cilia loss in response to hypoxia and inducers of 429 
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pseudohypoxia, and is consistent with studies that show axoneme length is influenced by hypoxia-430 
inducible mechanisms (Proulx-Bonneau and Annabi 2011; Wann, et al. 2013). Hypoxia is not just a 431 
driver of PCC/PGL formation (Opotowsky, et al. 2015; Rodriguez-Cuevas, et al. 1986), but is also 432 
a salient feature of many solid tumors, and may therefore modulate cilia presence in cancers more 433 
generally.  434 
 435 
There are a number of potential pathways through which HIF signalling could influence ciliogenesis 436 
and resorption. These include that stabilisation of HIF promotes transcription of Aurora-A kinase, 437 
which functions in regulation of ciliary resorption with HDAC6 (Pugacheva et al. 2007; Xu, et al. 438 
2010). Inhibition of the Aurora-A/HDAC6 pathway in PC12 cells prevented cilia loss in response to 439 
hypoxia and induction of pseudohypoxia. Collectively, these findings suggest that the reduction in 440 
cilia frequency in pseudohypoxic PCC is likely to be mediated by both HIF signalling and the 441 
Aurora-A/HDAC6 cilia resorption pathway, although, involvement of other regulators of cilia 442 
dynamics is also possible. 443 
 444 
Transcriptome analyses identified altered expression of gene modules associated with cilia-445 
mediated signalling in PCCs relative to adjacent adrenal medulla. Altered cilia-mediated signalling 446 
pathways included Hh, Wnt and Notch signalling. The role of cilia in regulation of cancer-linked 447 
signalling pathways is complex and context dependent (Oh and Katsanis 2013). For example, Wnt 448 
signalling, which is generally considered to be attenuated by the presence of a cilium, can be 449 
decreased in cells with shortened cilia yet activated by ablation of cilia (Lancaster et al. 2011; Oh 450 
and Katsanis 2013), while for Hh signalling the cilium activates the pathway in the presence of the 451 
sonic hedgehog ligand (Shh) and restrains signalling when Shh is absent (Hassounah, et al. 2012; 452 
Wong et al. 2009). There is also crosstalk between cilia-mediated signalling pathways, such as 453 
Notch signalling modulating Shh signalling, by regulating the ciliary localisation of the Hh signal 454 
transduction proteins Patched and Smoothened (Kong, et al. 2015). This complexity makes it 455 
difficult to interpret how alterations in cilia incidence and length may impact on specific pathways. 456 
Nevertheless, hierarchical clustering analyses separately grouped tumor and adrenal medulla 457 
samples based on changes of gene expression in multiple cilia-linked signalling pathways. This is 458 
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consistent with loss of cilia correlating with dysregulation of cilia-mediated signalling in PCCs. 459 
Disruption of Wnt signalling is particularly relevant to PCC/PGLs, with Wnt-altered tumors 460 
classified as one of four molecularly defined PCC/PGL subtypes (Fishbein et al. 2017).  461 
 462 
In addition to modulating signalling pathways that are dysregulated in tumorigenesis and cancer, 463 
the presence of a primary cilium may act as a checkpoint for cell division. We observed that 464 
disruption of cilia structure and function, by knockdown of IFT88 or Cep164, correlated with 465 
increased cellular proliferation of PC12 cells. This was accompanied by changes in gene 466 
expression that inhibited cell death pathways, while activating cell proliferation and tumor linked 467 
pathways. Together our data are concordant with cilia acting as a checkpoint for cell division in 468 
PC12 cells and suggest cilia loss promotes proliferation and perhaps tumorigenesis in PCC/PGL. 469 
Interestingly, we also observed that in PCC tissue there was a correlation between degree of cilia 470 
loss and Ki67 staining implying in vivo relevance of our findings in PC12 cells. 471 
 472 
In summary, we propose that in PCC/PGLs oncometabolite induced pseudohypoxia drives cilia 473 
loss through activation of the Aurora A kinase/HDAC6 cilia resorption pathway. In PCCs this cilia 474 
loss causes dysregulation of cilia-mediated signalling pathways including Hh, Wnt and Notch 475 
signalling, and is also likely to promote increased cellular proliferation (Figure 7). Hypoxia induced 476 
cilia resorption may be a feature of cancers more generally and represents a potential target to 477 
slow tumor progression. 478 
  479 
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Figure Legends 649 
 650 
Figure 1. Primary cilia incidence and length is reduced in PCCs relative to adjacent adrenal 651 
medulla. (A) Maximum intensity projections (MIP) of confocal Z-stacks of PCC and adjacent 652 
adrenal medulla. Tissue sections were processed for dual-immunofluorescent detection of the 653 
ciliary markers acetylated α-tubulin (green) and Arl13b (red). They were then counterstained with 654 
DAPI (blue) to detect nuclei. A single confocal section from the area demarked by the dashed box 655 
is shown zoomed (XY zoom). Individual cilia, indicated by arrows, are further enlarged in insets 1-6 656 
and are shown as surface rendered 3D images in the panels on the right. Scale bars = 10µm. (B) 657 
Quantification of primary cilium incidence in 27 paired PCC and adjacent adrenal medulla tissue 658 
samples. (C) Quantification of axoneme length (from confocal Z-stacks) from cells that had a 659 
primary cilium in PCC and adjacent adrenal medulla. (D) Cilia incidence and length correlate in 660 
both PCCs and adjacent adrenal medulla, with a more significant relationship in tumor than normal 661 
tissue. (E-F) Cilia incidence and length in 27 paired PCCs and adrenal medulla samples 662 
comparing individuals with (n=5) and without (n=22) germline mutations in VHL. (G-H) Cilia 663 
incidence and length in 47 PCC/PGL comparing those with a germline mutations in VHL (n=9), to 664 
tumors from patients with germline mutations in SDHx (n=9) and those without a known germline 665 
mutation in a pseudohypoxia linked gene (Con, n=29). (I) Cilia incidence in 33 PCC where more or 666 
less than 3% of cells labelled positively for Ki67. The number of cilia and nuclei were counted in 15 667 
randomly selected fields for each sample. Mean axonemal length was quantified from at least 50 668 
ciliated cells for each sample. Error bars indicate SD. Statistical tests: t-test (B, C, E, F, I), ANOVA 669 
(G, H), linear regression (D). * P<0.05, **P<0.01, ***P<0.001.  670 
 671 
Figure 2. Changes in expression of cilia-linked genes in the transcriptomes of PCCs relative 672 
to adrenal medulla. (A) Principal component analysis (PCA) of RNA-seq expression data from 12 673 
paired PCC and adjacent adrenal medulla tissue samples. (B) Volcano plot showing log10 FDR-674 
adjusted q-values versus log2 fold change between PCC and adjacent adrenal medulla. The 675 
vertical and horizontal dotted lines indicate 2x or -2x fold change and q = 0.01, respectively. (C) 676 
Heat map and hierarchical clustering depiction of all differentially expressed module eigengenes, 677 
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from a collection of 32 gene sets known to be associated with cilia structure and cilia-mediated 678 
signalling, that are altered between PCCs and adjacent adrenal medulla (D) Heat map and 679 
hierarchical clustering depiction of differentially expressed genes in the 680 
GO_NONMOTILE_PRIMARY_CILIUM pathway, comparing PCC and adjacent adrenal medulla 681 
samples. (E-G) Heat map and hierarchical clustering depictions of differentially expressed genes in 682 
three cilia-associated signalling pathways that are altered in PCCs relative to adjacent adrenal 683 
medulla: (E) HALLMARK_HEDGEHOG_SIGNALING; (F) BIOCARTA_WNT_PATHWAY; (G) 684 
GO_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY. Numbers shown at the 685 
bottom of the heat maps correspond to the sample IDs shown in the PCA (but are not prefixed with 686 
‘H’). 687 
 688 
Figure 3. Loss of primary cilia in PC12 cells promotes proliferation and alters gene 689 
expression. (A) Confocal images of PC12 cells cultured in the absence of serum for between 0 690 
and 72 hours. Cells were immunolabelled with anti-acetylated α-tubulin (green) and anti-Arl13b 691 
(red) for detection of primary cilia. Nuclei were stained with DAPI (blue). Cilia are indicated by 692 
arrows, or arrowheads where they are also shown zoomed in the insets.  Scale bars = 10µm. (B, 693 
C) Quantification of primary cilia incidence (B) and axonemal length (C) under conditions of serum 694 
starvation. (D) Confocal images of PC12 cells cultured for 48 hours after transfection with siRNA 695 
targeting IFT88, Cep164, or non-targeting control siRNAs (Con). Cells were immunolabelled to 696 
detect cilia (Arl13b, green) and the proliferation marker Ki67 (red). Nuclei were stained with DAPI 697 
(blue). Cilia are indicated by arrows and Ki67 positive cells by arrowheads. Scale bars = 10µm. (E-698 
H) Quantification of primary cilia incidence (E), the percentage of Ki67 positive cells (F), and 699 
relative cell numbers (G), 48 hours after transfection with siRNA targeting IFT88. (H-J) 700 
Quantification of primary cilia incidence (H), the percentage of Ki67 positive cells (I) and relative 701 
cell numbers (J), 48 hours after transfection with siRNA targeting Cep164. Cilia and Ki67 scoring 702 
were performed in 10 randomly selected fields for each experimental condition in three biological 703 
replicates. Mean axonemal length was quantified from at least 50 ciliated cells for each 704 
experimental condition. Cell counting was performed on six samples from three biological 705 
replicates. Error bars indicate 2x SEM. In box and whisker plots, the box represents median, upper 706 
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and lower quartiles and the whiskers the 10th and 90th centiles. Statistical tests: ANOVA (B, C), t-707 
test (E-G).  * P<0.05, **P<0.01, ***P<0.001. (K) Gene Ontology (GO) analysis of the transcriptome 708 
of PC12 cells transfected with siRNA targeting IFT88 or non-targeting control siRNAs, showing the 709 
top-ranking altered biological processes identified by Ingenuity Pathways Analysis. q values are 710 
depicted in red (E = 10 to the power of the following number). (L-M) Heat map and hierarchical 711 
clustering depictions of differentially expressed genes in altered pathways with the GO terms cell 712 
death (L), tumorigenesis of tissues (M) and cell proliferation of tumor cells (N). Numbers shown at 713 
the bottom of the heat maps correspond to sample IDs shown in Figure S3. 714 
 715 
Figure 4. Primary cilia are lost from PC12 cells when oxygen levels are reduced. (A) 716 
Confocal images of PC12 cells cultured in 21% or 1% oxygen for 24 hours, prior to return to 21% 717 
oxygen for 4, 8, 24 or 48 hours before processing for the detection of primary cilia as in Figure 3A. 718 
Scale bars = 10µm. (B, C) Quantification of primary cilia incidence (B) and axonemal length (C) 719 
after 24 hours of culture in 21% and 1% oxygen and subsequent recovery in 21% oxygen. (D, E) 720 
Comparison of primary cilia incidence (D) and axonemal length (E) upon serum starvation after 721 
culture in 21% or 1% oxygen. (F, G) Quantification of primary cilia incidence (F) and axonemal 722 
length (G) after 24 hours of culture in 1% oxygen in the presence of the the HIFa inhibitor 723 
FM19G11 or vehicle only control. (H, I) Quantification of primary cilia incidence (H) and axonemal 724 
length (I) after 24 hours of culture in 1% oxygen in cells transfected with non-targeting control 725 
siRNAs or siRNA targeting HIF1a. (J, K) Quantification of primary cilia incidence (J) and axonemal 726 
length (K) after 24 hours of culture in 1% oxygen in the presence of the the inhibitors trichostatin A 727 
(TSA), tubacin, PHA-680632 or vehicle only control. Cilia scoring was performed in 10 randomly 728 
selected fields for each experimental condition in three biological replicates. Mean axonemal 729 
length was quantified from at least 50 ciliated cells for each experimental condition. Error bars 730 
indicate 2x SEM. Box and whisker plots are as in Figure 3. Statistical tests: ANOVA.   * P<0.05, 731 
**P<0.01, ***P<0.001. 732 
 733 
Figure 5. Inducers of pseudohypoxia cause primary cilia loss and shortening in PC12 cells. 734 
(A) Schematic showing PCC linked enzymes and inhibitors used to block their action. (B, C) 735 
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Quantification of primary cilia incidence (B) and axonemal length (C) after 24 hours of culture in 736 
the presence or absence of DMOG. (D, E) Quantification of primary cilia incidence (D) and 737 
axonemal length (E) 48 hours after transfection with siRNAs targeting SDHB or non-targeting 738 
control siRNAs (Con). (F, G) Quantification of primary cilia incidence (F) and axonemal length (G) 739 
after 24 hours of culture in the presence or absence of malonate. (H, I) Quantification of primary 740 
cilia incidence (H) and axonemal length (I) after 24 hours of culture in the presence or absence of 741 
malonate (0.1mM), with or without α-ketoglutarate (α-KG) (J, K) Quantification of primary cilia 742 
incidence (J) and axonemal length (K) after 24 hours of culture in the presence or absence of 743 
monomethyl fumarate (MMF). (L-O) Quantification of primary cilia incidence (L, N) and axonemal 744 
length (M, O) 48 hours after transfection with siRNAs targeting FH (L, M) or VHL (N, O) compared 745 
to non-targeting control siRNAs (Con). (P, Q) Quantification of the percentage of Ki67 positive cells 746 
(P) and of relative cell numbers (Q), 48 hours after transfection with siRNAs targeting SDHB, VHL 747 
or control siRNAs. Cilia and Ki67 scoring was performed in 10 randomly selected fields for each 748 
experimental condition in three biological replicates. Mean axonemal length was quantified from at 749 
least 50 ciliated cells for each experimental condition. Cell counting was performed on six samples 750 
from three biological replicates. Error bars indicate 2x SEM. Box and whisker plots are as in Figure 751 
3. Statistical tests: ANOVA (B, C, F-K, P-Q), t-test (D, E, L-O). * P<0.05, **P<0.01, ***P<0.001. 752 
 753 
Figure 6. Inhibition of cilia resorption and hypoxic signalling prevents cilia loss caused by 754 
knockdown of SDHB and VHL. (A, B) Quantification of primary cilia incidence (A) and axonemal 755 
length (B) 48 hours after transfection with siRNAs targeting SDHB in the presence or absence of 756 
the inhibitors FM19G11, TSA, tubacin (Tub) and PHA-680632 (PHA), or vehicle only controls. 757 
Cells transfected with non-targeting control siRNAs (Con) were treated with the same inhibitors (C, 758 
D) Quantification of primary cilia incidence (C) and axonemal length (D) 48 hours after transfection 759 
with siRNAs targeting VHL in the presence or absence of the inhibitors used in Figure 6A-B. Cilia 760 
scoring was performed in 10 randomly selected fields for each experimental condition in three 761 
biological replicates. Mean axonemal length was quantified from at least 50 ciliated cells for each 762 
experimental condition. Error bars indicate 2x SEM. Box and whisker plots are as in Figure 3. 763 
Statistical tests: ANOVA. * P<0.05, **P<0.01, ***P<0.001. 764 
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 765 
Figure 7. Model illustrating the potential pathway from pseudohypoxia induced cilia loss to 766 
increased cell proliferation and dysregulation of tumorigenesis relevant cilia-mediated 767 
signalling pathways in PCCs. Proteins where germline mutations in the gene predispose to PCC 768 
are in orange boxes. H6 = HDAC6; AuroraA = aurora A kinase; FH = fumarate hydratase; SDH 769 
=succinate dehydrogenase; VHL = von Hippel Lindau protein; HIF = hypoxia inducible factor; PH = 770 
prolyl-hydroxylases; P = phosphate group; OH = hydroxyl group. 771 
 772 
Table	1:	Clinical	details	–	summary	table	
	 Paired	 Unpaired	 All	
Samples	(n)	 27	 20	 47	
Patients	(n)	 25	 15	 40	
Sex	 	 	 	
Male;	n	(%)	 12	(48%)	 7	(47%)	 19	(47.5%)	
Female;	n	(%)	 13	(52%)	 8	(53%)	 21	(52.5%)	
Age	(years)	 	 	 	
- Mean	+	SEM	 46.8	+	4.0	 46.2	+	3.4	 46.6	+	2.8	
- Range	 12	-	78	 15	-	68	 12	–	78	
Size	(mm)	 	 	 	
- Mean	+	SEM	 49	+	4	 47	+	7	 48	+	4	
- Range	 8	-	87	 13	-	120	 8	–	120	
Location	 	 	 	
- Adrenal	 27	(100%)	 7	(35%)	 34	(72%)	
- PGL	 0	(0%)	 13	(65%)	 13	(28%)	
Mode	of	diagnosis	 	 	 	
- Symptomatic	 9	(33%)	 9	(45%)	 18	(38%)	
- Incidental	 14	(52%)	 7	(35%)	 21	(45%)	




SDHA	 0	 1	 1	
SDHB	 1	 4	 5	
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Figure 1. Primary cilia incidence and length is reduced in PCCs relative to adjacent adrenal medulla. (A) Maximum 
intensity projections (MIP) of confocal Z-stacks of PCC and adjacent adrenal medulla. Tissue sections were processed for 
dual-immunofluorescent detection of the ciliary markers acetylated α-tubulin (green) and Arl13b (red). They were then coun-
terstained with DAPI (blue) to detect nuclei. A single confocal section from the area demarked by the dashed box is shown 
zoomed (XY zoom). Individual cilia, indicated by arrows, are further enlarged in insets 1-6 and are shown as surface 
rendered 3D images in the panels on the right. Scale bars = 10µm. (B) Quantification of primary cilium incidence in 27 
paired PCC and adjacent adrenal medulla tissue samples. (C) Quantification of axoneme length (from confocal Z-stacks) 
from cells that had a primary cilium in PCC and adjacent adrenal medulla. (D) Cilia incidence and length correlate in both 
PCCs and adjacent adrenal medulla, with a more significant relationship in tumor than normal tissue. (E-F) Cilia incidence 
and length in 27 paired PCCs and adrenal medulla samples comparing individuals with (n=5) and without (n=22) germline 
mutations in VHL. (G-H) Cilia incidence and length in 47 PCC/PGL comparing those with a germline mutations in VHL (n=9), 
to tumors from patients with germline mutations in SDHx (n=9) and those without a known germline mutation in a pseudohy-
poxia linked gene (Con, n=29). (I) Cilia incidence in 33 PCC where more or less than 3% of cells labelled positively for Ki67. 
The number of cilia and nuclei were counted in 15 randomly selected fields for each sample. Mean axonemal length was 
quantified from at least 50 ciliated cells for each sample. Error bars indicate SD. Statistical tests: t-test (B, C, E, F, I), ANOVA 
(G, H), linear regression (D). * P<0.05, **P<0.01, ***P<0.001. 
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Figure 2. Changes in expression of cilia-linked genes in the transcriptomes of PCCs relative to adrenal medulla. (A) Principal component 
analysis (PCA) of RNA-seq expression data from 12 paired PCC and adjacent adrenal medulla tissue samples. (B) Volcano plot showing log10 
FDR-adjusted q-values versus log2 fold change between PCC and adjacent adrenal medulla. The vertical and horizontal dotted lines indicate 2x or 
-2x fold change and q = 0.01, respectively. (C) Heat map and hierarchical clustering depiction of all differentially expressed module eigengenes, from 
a collection of 32 gene sets known to be associated with cilia structure and cilia-mediated signalling, that are altered between PCCs and adjacent 
adrenal medulla (D) Heat map and hierarchical clustering depiction of differentially expressed genes in the GO_NONMOTILE_PRIMARY_CILIUM 
pathway, comparing PCC and adjacent adrenal medulla samples. (E-G) Heat map and hierarchical clustering depictions of differentially expressed 
genes in three cilia-associated signalling pathways that are altered in PCCs relative to adjacent adrenal medulla: (E) HALLMARK_HEDGE-
HOG_SIGNALING; (F) BIOCARTA_WNT_PATHWAY; (G) GO_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY. Numbers shown 
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Figure 3. Loss of primary cilia in PC12 cells promotes proliferation and alters gene expression. (A) Confocal images 
of PC12 cells cultured in the absence of serum for between 0 and 72 hours. Cells were immunolabelled with anti-acetylated 
α-tubulin (green) and anti-Arl13b (red) for detection of primary cilia. Nuclei were stained with DAPI (blue). Cilia are indicated 
by arrows, or arrowheads where they are also shown zoomed in the insets.  Scale bars = 10µm. (B, C) Quantification of 
primary cilia incidence (B) and axonemal length (C) under conditions of serum starvation. (D) Confocal images of PC12 
cells cultured for 48 hours after transfection with siRNA targeting IFT88, Cep164, or non-targeting control siRNAs (Con). 
Cells were immunolabelled to detect cilia (Arl13b, green) and the proliferation marker Ki67 (red). Nuclei were stained with 
DAPI (blue). Cilia are indicated by arrows and Ki67 positive cells by arrowheads. Scale bars = 10µm. (E-H) Quantification 
of primary cilia incidence (E), the percentage of Ki67 positive cells (F), and relative cell numbers (G), 48 hours after transfec-
tion with siRNA targeting IFT88. (H-J) Quantification of primary cilia incidence (H), the percentage of Ki67 positive cells (I) 
and relative cell numbers (J), 48 hours after transfection with siRNA targeting Cep164. Cilia and Ki67 scoring were 
performed in 10 randomly selected fields for each experimental condition in three biological replicates. Mean axonemal 
length was quantified from at least 50 ciliated cells for each experimental condition. Cell counting was performed on six 
samples from three biological replicates. Error bars indicate 2x SEM. In box and whisker plots, the box represents median, 
upper and lower quartiles and the whiskers the 10th and 90th centiles. Statistical tests: ANOVA (B, C), t-test (E-G).  * 
P<0.05, **P<0.01, ***P<0.001. (K) Gene Ontology (GO) analysis of the transcriptome of PC12 cells transfected with siRNA 
targeting IFT88 or non-targeting control siRNAs, showing the top-ranking altered biological processes identified by Ingenui-
ty Pathways Analysis. q values are depicted in red (E = 10 to the power of the following number). (L-M) Heat map and 
hierarchical clustering depictions of differentially expressed genes in altered pathways with the GO terms cell death (L), 
tumorigenesis of tissues (M) and cell proliferation of tumor cells (N). Numbers shown at the bottom of the heat maps corre-
spond to sample IDs shown in Figure S3.
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Figure 4. Primary cilia are lost from PC12 cells when oxygen levels are reduced. (A) (Confocal images of PC12 cells 
cultured in 21% or 1% oxygen for 24 hours, prior to return to 21% oxygen for 4, 8, 24 or 48 hours before processing for the 
detection of primary cilia as in Figure 3A. Scale bars = 10µm. (B, C) Quantification of primary cilia incidence (B) and axone-
mal length (C) after 24 hours of culture in 21% and 1% oxygen and subsequent recovery in 21% oxygen. (D, E) Comparison 
of primary cilia incidence (D) and axonemal length (E) upon serum starvation after culture in 21% or 1% oxygen. (F, G) 
Quantification of primary cilia incidence (F) and axonemal length (G) after 24 hours of culture in 1% oxygen in the presence 
of the the HIFα inhibitor FM19G11 or vehicle only control. (H, I) Quantification of primary cilia incidence (H) and axonemal 
length (I) after 24 hours of culture in 1% oxygen in cells transfected with non-targeting control siRNAs or siRNA targeting 
HIF1α. (J, K) Quantification of primary cilia incidence (J) and axonemal length (K) after 24 hours of culture in 1% oxygen in 
the presence of the the inhibitors trichostatin A (TSA), tubacin, PHA-680632 or vehicle only control. Cilia scoring was 
performed in 10 randomly selected fields for each experimental condition in three biological replicates. Mean axonemal 
length was quantified from at least 50 ciliated cells for each experimental condition. Error bars indicate 2x SEM. Box and 


















































































































































































































































































































































Figure 5. Inducers of pseudohypoxia cause primary cilia loss and shortening in PC12 cells. (A) Schematic showing 
PCC linked enzymes and inhibitors used to block their action. (B, C) Quantification of primary cilia incidence (B) and axone-
mal length (C) after 24 hours of culture in the presence or absence of DMOG. (D, E) Quantification of primary cilia incidence 
(D) and axonemal length (E) 48 hours after transfection with siRNAs targeting SDHB or non-targeting control siRNAs (Con). 
(F, G) Quantification of primary cilia incidence (F) and axonemal length (G) after 24 hours of culture in the presence or 
absence of malonate. (H, I) Quantification of primary cilia incidence (H) and axonemal length (I) after 24 hours of culture in 
the presence or absence of malonate (0.1mM), with or without α-ketoglutarate (α-KG) (J, K) Quantification of primary cilia 
incidence (J) and axonemal length (K) after 24 hours of culture in the presence or absence of monomethyl fumarate (MMF). 
(L-O) Quantification of primary cilia incidence (L, N) and axonemal length (M, O) 48 hours after transfection with siRNAs 
targeting FH (L, M) or VHL (N, O) compared to non-targeting control siRNAs (Con). (P, Q) Quantification of the percentage 
of Ki67 positive cells (P) and of relative cell numbers (Q), 48 hours after transfection with siRNAs targeting SDHB, VHL or 
control siRNAs. Cilia and Ki67 scoring was performed in 10 randomly selected fields for each experimental condition in 
three biological replicates. Mean axonemal length was quantified from at least 50 ciliated cells for each experimental condi-
tion. Cell counting was performed on six samples from three biological replicates. Error bars indicate 2x SEM. Box and 















































































































































































































































Figure 6. Inhibition of cilia resorption and hypoxic signalling prevents cilia loss caused by knockdown of SDHB 
and VHL. (A, B) Quantification of primary cilia incidence (A) and axonemal length (B) 48 hours after transfection with 
siRNAs targeting SDHB in the presence or absence of the inhibitors FM19G11, TSA, tubacin (Tub) and PHA-680632 (PHA), 
or vehicle only controls. Cells transfected with non-targeting control siRNAs (Con) were treated with the same inhibitors (C, 
D) Quantification of primary cilia incidence (C) and axonemal length (D) 48 hours after transfection with siRNAs targeting 
VHL in the presence or absence of the inhibitors used in Figure 6A-B. Cilia scoring was performed in 10 randomly selected 
fields for each experimental condition in three biological replicates. Mean axonemal length was quantified from at least 50 
ciliated cells for each experimental condition. Error bars indicate 2x SEM. Box and whisker plots are as in Figure 3. Statisti-
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Figure 7. Model illustrating the potential pathway from pseudohypoxia induced cilia loss to increased cell prolif-
eration and dysregulation of tumorigenesis relevant cilia-mediated signalling pathways in PCCs. Proteins where 
germline mutations in the gene predispose to PCC are in orange boxes. H6 = HDAC6; AuroraA = aurora A kinase; FH = 
fumarate hydratase; SDH =succinate dehydrogenase; VHL = von Hippel Lindau protein; HIF = hypoxia inducible factor; 
PH = prolyl-hydroxylases; P = phosphate group; OH = hydroxyl group.
